Mega Lifesciences PCL
SET:MEGA

Watchlist Manager

Mega Lifesciences PCL

SET:MEGA

Watchlist

Dividends

Discount Rate

Price: 34 THB 1.49% Market Closed

Market Cap: 29.6B THB

Have any thoughts about
Mega Lifesciences PCL?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

Add Price Alert

Price Target:

Last Price: 34 THB

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

MEGA Alert

Mega Lifesciences PCL

+0.5 (+1.49%)

52 Week Range	33.5 44
Price Target

We'll email you a reminder when the closing price reaches THB.

Save Alert

Choose the stock you wish to monitor with a price alert.

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Mega Lifesciences PCL

What unique competitive advantages
does Mega Lifesciences PCL hold over its rivals?

What risks and challenges
does Mega Lifesciences PCL face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Mega Lifesciences PCL.

What unique competitive advantages
does Mega Lifesciences PCL hold over its rivals?

What risks and challenges
does Mega Lifesciences PCL face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Mega Lifesciences PCL.

Provide P/S
for Mega Lifesciences PCL.

Provide P/E
for Mega Lifesciences PCL.

Provide P/OCF
for Mega Lifesciences PCL.

Provide P/FCFE
for Mega Lifesciences PCL.

Provide P/B
for Mega Lifesciences PCL.

Provide EV/S
for Mega Lifesciences PCL.

Provide EV/GP
for Mega Lifesciences PCL.

Provide EV/EBITDA
for Mega Lifesciences PCL.

Provide EV/EBIT
for Mega Lifesciences PCL.

Provide EV/OCF
for Mega Lifesciences PCL.

Provide EV/FCFF
for Mega Lifesciences PCL.

Provide EV/IC
for Mega Lifesciences PCL.

Show me price targets
for Mega Lifesciences PCL made by professional analysts.

What are the Revenue projections
for Mega Lifesciences PCL?

How accurate were the past Revenue estimates
for Mega Lifesciences PCL?

What are the Net Income projections
for Mega Lifesciences PCL?

How accurate were the past Net Income estimates
for Mega Lifesciences PCL?

What are the EPS projections
for Mega Lifesciences PCL?

How accurate were the past EPS estimates
for Mega Lifesciences PCL?

What are the EBIT projections
for Mega Lifesciences PCL?

How accurate were the past EBIT estimates
for Mega Lifesciences PCL?

Compare the revenue forecasts
for Mega Lifesciences PCL with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Mega Lifesciences PCL and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Mega Lifesciences PCL against its competitors.

Analyze the profit margins
(gross, operating, and net) of Mega Lifesciences PCL compared to its peers.

Compare the P/E ratios
of Mega Lifesciences PCL against its peers.

Discuss the investment returns and shareholder value creation
comparing Mega Lifesciences PCL with its peers.

Analyze the financial leverage
of Mega Lifesciences PCL compared to its main competitors.

Show all profitability ratios
for Mega Lifesciences PCL.

Provide ROE
for Mega Lifesciences PCL.

Provide ROA
for Mega Lifesciences PCL.

Provide ROIC
for Mega Lifesciences PCL.

Provide ROCE
for Mega Lifesciences PCL.

Provide Gross Margin
for Mega Lifesciences PCL.

Provide Operating Margin
for Mega Lifesciences PCL.

Provide Net Margin
for Mega Lifesciences PCL.

Provide FCF Margin
for Mega Lifesciences PCL.

Show all solvency ratios
for Mega Lifesciences PCL.

Provide D/E Ratio
for Mega Lifesciences PCL.

Provide D/A Ratio
for Mega Lifesciences PCL.

Provide Interest Coverage Ratio
for Mega Lifesciences PCL.

Provide Altman Z-Score Ratio
for Mega Lifesciences PCL.

Provide Quick Ratio
for Mega Lifesciences PCL.

Provide Current Ratio
for Mega Lifesciences PCL.

Provide Cash Ratio
for Mega Lifesciences PCL.

What is the historical Revenue growth
over the last 5 years for Mega Lifesciences PCL?

What is the historical Net Income growth
over the last 5 years for Mega Lifesciences PCL?

What is the current Free Cash Flow
of Mega Lifesciences PCL?

Discuss the annual earnings per share (EPS)
trend over the past five years for Mega Lifesciences PCL.

P/S
Price to Sales

1.9

Current

2.4

Median

2.5

Industry

Lower than median

Lower than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S

1.9

Market Cap

29.6B THB

Revenue

15.8B THB

All Countries

Forward Multiples

			Market Cap	P/S
TH	M	Mega Lifesciences PCL SET:MEGA	29.6B THB	1.9
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	776 550.9T JPY	4 211 733
US		Eli Lilly and Co NYSE:LLY	749.7B USD	18.3
UK		Dechra Pharmaceuticals PLC LSE:DPH	440.4B GBP	578.3
DK		Novo Nordisk A/S CSE:NOVO B	3.4T DKK	12.4
US		Johnson & Johnson NYSE:JNJ	372B USD	4.2
US		Merck & Co Inc NYSE:MRK	257.3B USD	4.1
CH		Roche Holding AG SIX:ROG	200.4B CHF	3.4
UK		AstraZeneca PLC LSE:AZN	162.7B GBP	4.2
CH		Novartis AG SIX:NOVN	179.9B CHF	4.1
IE	E	Endo International PLC LSE:0Y5F	146B USD	63

				Revenue Growth
TH	M	Mega Lifesciences PCL SET:MEGA	Average P/S: 382 947.9 1.9	17%
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	4 211 733	22%
US		Eli Lilly and Co NYSE:LLY	18.3	110%
UK		Dechra Pharmaceuticals PLC LSE:DPH	578.3	29%
DK		Novo Nordisk A/S CSE:NOVO B	12.4	77%
US		Johnson & Johnson NYSE:JNJ	4.2	12%
US		Merck & Co Inc NYSE:MRK	4.1	20%
CH		Roche Holding AG SIX:ROG	3.4	15%
UK		AstraZeneca PLC LSE:AZN	4.2	35%
CH		Novartis AG SIX:NOVN	4.1	17%
IE	E	Endo International PLC LSE:0Y5F	63	N/A

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/S

1.8

2-Years Forward

P/S

1.7

3-Years Forward

P/S

1.6

Mega Lifesciences PCL
SET:MEGA

P/S
Price to Sales

P/S Forward Multiples

See Also

Company

Help

Tools

Stocks

Mega Lifesciences PCL SET:MEGA

P/S Price to Sales

P/S Forward Multiples

See Also

Company

Help

Tools

Stocks

Mega Lifesciences PCL
SET:MEGA

P/S
Price to Sales